FDA Accepts Biologics License Application for Cosibelimab in Skin Cancer: Checkpoint Therapeutics Makes Major Strides

Checkpoint Therapeutics Announces FDA Filing Acceptance of Biologics License Application for Cosibelimab in Metastatic Understanding the Prescription Drug User Fee Act (“PDUFA”) Goal Date On January 3, 2024, the Prescription Drug User Fee Act (“PDUFA”) goal date for Cosibelimab in Metastatic will mark a significant milestone for Checkpoint Therapeutics, Inc. The FDA has indicated that…

Read More

Revving Up: Driver Assistance System Market Set to Reach $73 Billion by 2030, According to Market Research Future (MRFR) Report

Increasing Interest towards Vehicle Automation to Drive the Driver Assistance System Market New York, US, March 02, 2023 (GLOBE NEWSWIRE) — Market Research Future (MRFR) Report Overview: According to a detailed research report by Market Research Future (MRFR), the Driver Assistance System Market is expected to witness significant growth in the coming years. The report…

Read More

Deutsche Börse’s Cash Markets See 35% Drop in Turnover, But Show Slight Improvement in February

Deutsche Börse’s cash markets turnover drops 35% YoY but strengthens slightly on monthly basis in February Trading volumes on Börse Frankfurt In February 2023 came in at €2.93 billion, down from €3.01 billion in January 2023. Equities on Deutsche Börse generated € 96.93 billion last month, while trading in ETFs/ETCs/ETNs accounted for €14.84 billion of…

Read More

Option Care Health: A Heartfelt Announcement of Secondary Offering and Common Stock Repurchase

Option Care Health Announces Pricing of Secondary Offering of 13,000,000 Shares of Common Stock and Common Stock Repurchase BANNOCKBURN, Ill., March 01, 2023 (GLOBE NEWSWIRE) — Option Care Health, Inc. (“Option Care Health” or the “Company”) (NASDAQ: OPCH) announced today that an affiliate of Walgreens Boots Alliance, Inc. (the “Selling Stockholder”) has agreed to sell…

Read More

Hey Investors, Listen Up! Pomerantz Law Firm is on the Case: A Shareholder Alert for CVRx Inc. Investigation

Oh No, Another Shareholder Alert! Here we go again, folks. It seems like every other day there is news about yet another company being investigated for claims of wrongdoing. This time, it’s CVRx, Inc. (NASDAQ: CVRX) in the hot seat. According to a recent press release from Pomerantz LLP, they are looking into allegations involving…

Read More

Act Now: Protect Your Investment with BLRX Deadline Approaching – A Call to Action from Leading Investor Rights Law Firm, Rosen

BLRX DEADLINE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages BioLineRx Ltd. Investors to Secure Counsel Before Important March 6 Deadline in Securities Class Action – BLRX Background Information NEW YORK, March 02, 2023 (GLOBE NEWSWIRE) — Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of BioLineRx Ltd. (NASDAQ:…

Read More

Attention Shareholders: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Wayfair Inc.

Understanding the Investigation: Wayfair Inc. and Shareholder Claims Introduction Attention all shareholders of Wayfair Inc.! The Pomerantz Law Firm is currently conducting an investigation on behalf of investors regarding claims against the company. If you are invested in Wayfair Inc. (NYSE: W), it is advised that you contact Robert S. Willoughby at [email protected] or call…

Read More

Secure Your Investment: Rosen, a Leading Law Firm, Urges Inspirato Incorporated Investors to Seek Counsel Before Securities Class Action Deadline

ROSEN, A TOP RANKED LAW FIRM, Encourages Inspirato Incorporated Investors to Secure Counsel Before Important Deadline in Securities Cla… New York, March 01, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Inspirato Incorporated (NASDAQ: ISPO) between May 11, 2022 and December 15, 2022,…

Read More